To determine the frequency and timing of symptoms and to evaluate the effectiveness of a sepsis-screening pathway in term and near-term infants, data were collected prospectively for a period of 1 year from December 1, 2000, to November 30, 2001. Results confirmed that a sepsis-screening pathway using a combination of at least 2 serial complete blood cell count and C-reactive protein measurements in both symptomatic and asymptomatic infants is a safe, simple strategy that prevents unnecessary treatment of infants with risk factors with antibiotics. However, most infants with presumed or suspected early-onset sepsis are symptomatic. Routine treatment of asymptomatic infants with risk factors or prior treatment with intrapartum antibiotics is unnecessary. A combined approach of screening in the presence of risk factors and /or symptoms of sepsis and adequate follow-up for infants discharged at less than 72 hours of age may help reduce unnecessary treatment of infants with antibiotics.
Get full access to this article
View all access options for this article.
References
1.
1. Escobar GJ, Zukin T, Usatin MS, et al. Early discontinuation of antibiotic treatment in newborns admitted to rule out sepsis: a decision rule. Pediatr Infect Disj. 1994;13(10):860-866. Symptomatic infant
2.
2. Escobar GJ. The neonatal “sepsis work-up”: personal reflections on the development of an evidence-based approach toward newborn infections in a managed care organization. Pediatrics. 1999;103(1 Suppl E):360-373.
3.
3. Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis work-ups in infants? 2,000 grams at birth: a population-based study. Pediatrics. 2000;106:256-263.
4.
4. Wientzen RLJr, Mc Cracken GHJr, et al. Pathogenesis and management of neonatal sepsis and meningitis. Curr Probl Pediatr1977;8:1-61.
6. Morita JY, O'Brien KL, Schuchat A. Prevention of perinatal group B streptococcal infections. Pediatr Infect Disj1999;18:279-280.
7.
7. Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule and C-reactive protein in preterm very low birthweight infants. Arch Dis Child. 1997;77:F221-F227.
8.
8. Kilster H, Weiss M, Willeitner AE, et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet. 1998;352:1271-1277.
9.
9. Werrich E, Rabin RL, Maldonado Y, et al. Ne Lutrophil CD1 lb expression as a diagnostic marker for early-onset neonatal infection. J Pediatr. 1998;132:445-451.
10.
10. Franz AR, Kron M, Pohlandt F, Steinbach G. Conmparison of procalcitonin with interleukin-8, C-reactive protein anid differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediati-Infect Dis J. 1999;18:666-671.
11.
11. Nupponen I, Andersson S, et al. Neutrophil CD1lb expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics. 2001;108(1). URL: hhtp:/w/wwr.pediatrics.org/cgi/content/full/108/1/e12.
12.
12. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleuikin-8 and C-reactive protein as markers of bacterial infections. Pediatnics. 1999;104:447-453.
13.
13. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Network.J Pediatr1996;129:63-71.
14.
14. Wiswell TE, Stoll BJ, Tuggle JM. Management of asymptomatic, term gestation neonates born to mothers treated with intrapartum antibiotics. Pediatr Infect Dis J. 1990;9(11):826-831.
15.
15. Hammerschlag MR, Klein JO, Herschel M, et al. Patterns of use of antibiotics in two newborn nurseries. N Engl JMed. 1977;296:1268-1269.
16.
16. Townsend TR, Shapiro M, Rosner B, Kass EH. Use of antimicrobial drugs in general hospitals. IV. Infants and children. Pediatrics. 1979;64:573-578.
17.
17. Schwersenski J, Mc Intyre L, Bauer CR. Lumbar puncture frequency and cerebrospinal fluid analysis in the neonate. Am JDis Child. 1991;145:554-558.
18.
18. Guyer B, Martin JA, Mac Dorman MF, et al. Annual summary of vital statistics-1996. Pediatrics. 1997;100:905-911.
19.
19. Wiswell TE, Baumgart S, Gannon CM, Spitzer AR. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed?Pediatrics. 1995;95:803-806.
20.
20. Merced RL, Wiswell TE, Hume RF. Outcome of term gestation neonate whose mothers received intrapartum antibiotics for suspected chorioamnionitis. Am J Perinatol. 1993;10:365-368.
21.
21. Philip AGS, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure experience with infants initially admitted to a well-baby nursery. Pediatrics. 2000;106(1).
22.
22. Yancy MK, Duff P, Kubilis P, et al. Risk factors for neonatal sepsis. Obstet GIynecol. 1996;87(2):188-194.
23.
23. Benitz WE, Gould JB, Druzin ML. Risk factor for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103(6):e77-e77. Available at http://pediatrics.org/cgi/content/full/103/6/e77.
24.
24. Boyer KM, Gadzala CA, Burd LI, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Inifect Dis. 1983;148(5):795-801.
25.
25. Persson K, Christensen KK, Christensen P, et al. Asyrmptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis. 1985;17(2):195-199.
26.
27. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. Reference values for neutrophilic cells. J Pediatr1979;95:89-98.
27.
28. Schelonka RL, Yoder BA, des Jardins SE, Hall RB, Butler J. Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr1994;125:603-606.
28.
28. Schelonka RL, Yoder BA, Bradley A. The WBC count and differential: its uses and misuses. Contemnp Obstet Gynecol. 1996;13:124-166.
29.
29. Murray BE. Can antibiotic resistance be controlled?N Engl J Med. 1994;330:1229-1230.
30.
30. Boyce JM. Vancomycin-resistant enterococcus. Infect Dis Clin North Am. 1997;11:367-384.
31.
31. Benitz WER, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics. 1999;103(6):e78-e78. Available at http://wwrw.pediatrics.org/cgi/content/full/103/6/e78.
32.
32. Spector SA, Ticknor W, Grossman M. Study of the usefulness of clinical and hematologic findings in the diagnosis of neonatal bacterial infections. Clin Pediatr (Phila). 1981;20(6):385-392.
33.
33. Ehl S, Gering B, Bartmann P, et al. Creactive protein is a usefuil marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics. 1997;99:216-222.
34.
34. Mathers N, Pohlandt F. Diagnostic audit of C-reactive protein in ineonatal infection. Eur J Pediatr1987;146:147-151.
35.
35. Pourcyrous M, Bada HS, Korones SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics. 1993;92:431-435.
36.
36. Benitz WE, Han MY, Madan A, Ramachandran P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102(4). URL: http//www.pediatrics.org/cgi/content/full/102/4/e41.
37.
37. Messer J, Eyer D, Donato L, et al. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr. 1996;129:574-580.
38.
38. Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr1996;128:570-573.
39.
39. Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol. 1991;18:361-381.
40.
40. Sabel KG, Hanson LA. The clinical usefulness of C-reactive protein (CRP) determinations in bacterial meningitis and septicemia in infancy. Acta Paeditr Scand. 1974;63:381-388.
41.
41. Chiesa C, Signore F, Assumma M, et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clin Chem. 2001;47(6):1016-1022.
42.
42. Yagupsky P, Menegus MA, Powell KR. The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital. Pediatr Infect Dis J. 1991;10(11):801-808.
43.
43. Bromberger P, Lawrence JM, Braun D, et al. Intrapartum antibiotic use and timing of onset of clinical signs of illness in term infants with early onset group B streptococcal infection. Pediatrics. 2000;106 (2 pt 1):244-250.
